Wellesley Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History

Wellesley Investment Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-6,208	Closed	-$296K	–	110
2019 Q1	$296K	Sell	6,208 -1,628	-21%	-$81.1K	0.1%	94
2018 Q4	$407K	Hold	7,836	–	–	0.14%	79
2018 Q3	$486K	Hold	7,836	–	–	0.16%	77
2018 Q2	$433K	Hold	7,836	–	–	0.15%	81
2018 Q1	$495K	Buy	7,836 +375	+5%	+$24.1K	0.18%	81
2017 Q4	$457K	Hold	7,461	–	–	0.17%	80
2017 Q3	$475K	Buy	7,461 +1,000	+15%	+$58.4K	0.2%	78
2017 Q2	$360K	Hold	6,461	–	–	0.15%	84
2017 Q1	$351K	Hold	6,461	–	–	0.16%	83
2016 Q4	$377K	Buy	6,461 +1,700	+36%	+$92.9K	0.18%	77
2016 Q3	$256K	Buy	4,761 +150	+3%	+$9.63K	0.13%	87
2016 Q2	$339K	Sell	4,611 -1,600	-26%	-$113K	0.18%	73
2016 Q1	$397K	Hold	6,211	–	–	0.24%	69
2015 Q4	$427K	Buy	+6,211	New	+$410K	0.29%	59

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellesley Investment Partners's BMY Position: Q2 2019 in Review

Wellesley Investment Partners sold out of Bristol-Myers Squibb (BMY) in Q2 2019, closing a stake of 6,208 shares — an estimated $296K sold.

Wellesley Investment Partners first reported a position in BMY in Q4 2015 and held it in 14 quarters. The position peaked at $495K in Q1 2018. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

Wellesley Investment Partners reported no remaining Bristol-Myers Squibb position as of Q2 2019 after selling out during the quarter.
Wellesley Investment Partners sold 6,208 Bristol-Myers Squibb shares in Q2 2019, an estimated $296K.
Wellesley Investment Partners first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 14 quarters.
Wellesley Investment Partners's Bristol-Myers Squibb position peaked at $495K in Q1 2018.
1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on Wellesley Investment Partners's 13F filing for Q2 2019, filed 5 Aug 2019.